377 results on '"Wesch, Daniela"'
Search Results
2. Editorial: New insights into innate immune cell-based immunotherapies in cancer
3. Vdelta1 T cells are more resistant than Vdelta2 T cells to the immunosuppressive properties of galectin-3
4. Reprogramming of human γδ T cells by expression of an anti-CD19 TCR fusion construct (εTRuC) to enhance tumor killing
5. 1005 BiXAb® MAIT Engagers: solving the problems of classical T-cell engagers in the treatment of solid tumors
6. Monocyte-dependent co-stimulation of cytokine induction in human γδ T cells by TLR8 RNA ligands
7. Reprogramming of human γδ T cells by expression of an anti-CD19 TCR fusion construct (εTRuC) to enhance tumor killing.
8. Chemotherapy‐induced release of ADAM17 bearing EV as a potential resistance mechanism in ovarian cancer
9. In vitro expansion of Vγ9Vδ2 T cells for immunotherapy
10. Real-time cell analysis (RTCA) to measure killer cell activity against adherent tumor cells in vitro
11. The γδTCR combines innate immunity with adaptive immunity by utilizing spatially distinct regions for agonist selection and antigen responsiveness
12. Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinoma
13. Hepatic myofibroblasts exert immunosuppressive effects independent of the immune checkpoint regulator PD-L1 in liver metastasis of pancreatic ductal adenocarcinoma
14. Human Vδ2 T cells are a major source of interleukin-9
15. The Ambiguous Role of γδ T Lymphocytes in Antitumor Immunity
16. Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinoma
17. Monitoring and functional characterization of the lymphocytic compartment in pancreatic ductal adenocarcinoma patients
18. Regulatory functions of γδ T cells
19. Influence of physical activity on the immune system in breast cancer patients during chemotherapy
20. Supplementary Figure Legends from Novel Bispecific Antibodies Increase γδ T-Cell Cytotoxicity against Pancreatic Cancer Cells
21. Data from Novel Bispecific Antibodies Increase γδ T-Cell Cytotoxicity against Pancreatic Cancer Cells
22. Supplementary Methods from Novel Bispecific Antibodies Increase γδ T-Cell Cytotoxicity against Pancreatic Cancer Cells
23. Supplementary Figure Legends 1-2 from Toll-like Receptors 3 and 7 Agonists Enhance Tumor Cell Lysis by Human γδ T Cells
24. Supplementary Figure 1 from Toll-like Receptors 3 and 7 Agonists Enhance Tumor Cell Lysis by Human γδ T Cells
25. Supplementary Figures 1 - 7 from Novel Bispecific Antibodies Increase γδ T-Cell Cytotoxicity against Pancreatic Cancer Cells
26. Supplementary Figure 2 from Toll-like Receptors 3 and 7 Agonists Enhance Tumor Cell Lysis by Human γδ T Cells
27. Data from Toll-like Receptors 3 and 7 Agonists Enhance Tumor Cell Lysis by Human γδ T Cells
28. Activation of Toll-like Receptor 2 (TLR2) induces Interleukin-6 trans-signaling
29. 18:1/18:1-Dioleoyl-phosphatidylglycerol prevents alveolar epithelial apoptosis and profibrotic stimulus in a neonatal piglet model of acute respiratory distress syndrome
30. List of Contributors
31. Dormancy: An Evolutionary Key Phenomenon in Cancer Development a
32. Stimulatory and inhibitory activity of STING ligands on tumor-reactive human gamma/delta T cells
33. Tumor cell lysis and synergistically enhanced antibody-dependent cell-mediated cytotoxicity by NKG2D engagement with a bispecific immunoligand targeting the HER2 antigen
34. Phenotype and regulation of immunosuppressive Vδ2-expressing γδ T cells
35. The Responsiveness of Human Vδ1 γδ T Cells to Borrelia burgdorferi Is Largely Restricted to Synovial-Fluid Cells from Patients with Lyme Arthritis
36. Initiation of Pancreatic Cancer: The Interplay of Hyperglycemia and Macrophages Promotes the Acquisition of Malignancy-Associated Properties in Pancreatic Ductal Epithelial Cells
37. Modulation of γδ T cell responses by TLR ligands
38. Innate immune functions of human γδ T cells
39. L1CAM promotes enrichment of immunosuppressive T cells in human pancreatic cancer correlating with malignant progression
40. Different properties of VEGF-antagonists: Bevacizumab but not Ranibizumab accumulates in RPE cells
41. Tumor cell lysis and synergistically enhanced antibody-dependent cell-mediated cytotoxicity by NKG2D engagement with a bispecific immunoligand targeting the HER2 antigen.
42. Affinity Maturation of B7-H6 Translates into Enhanced NK Cell–Mediated Tumor Cell Lysis and Improved Proinflammatory Cytokine Release of Bispecific Immunoligands via NKp30 Engagement
43. Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: Heterogeneous involvement of the “a disintegrin and metalloproteases” 10 and 17
44. Human γδ T cells: Candidates for the development of immunotherapeutic strategies
45. Tumor resistance mechanisms and their consequences on γδ T cell activation
46. Regulatory functions of γδ T cells
47. Differential expression of natural killer receptors on Vdelta1 alpha delta T cells in HIV-1 infected individuals
48. Topical application of phosphatidyl-inositol-3,5-bisphosphate for acute lung injury in neonatal swine
49. Inositol-Trisphosphate Reduces Alveolar Apoptosis and Pulmonary Edema in Neonatal Lung Injury
50. γδ T cells, their T cell receptor usage and role in human diseases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.